Do you leak when you cry?, page-2

Patience from here IMO - the path is already laid out.
(understand the frustration tho!)

We have a qtrly in 10 or so days which will be pivotal in showing us how much traction they have made in the US with their sales force agreement.

However the big ticket item for me is these snippets from the chairmans address to shareholders on Nov 24:
"We are also conducting a post-approval clinical trial, the primary goal of which is to provide data for health economics studies of PeriCoach. This trial will give us independent evidence to give to the health departments and private health insurers around the world so that the use of the PeriCoach is funded by these agencies"
"With the PeriCoach, Analytica can offer all seven points to a potential multinational partner - they want a product that has been tested in the market place, that is ready to go and has been de-risked and we have done this. Our strategy is to approach any potential partner once we have the results of the clinical trial. The independent data and the health economics outcomes are important, but the trial’s secondary endpoint examining Female Sexual Dysfunction is equally exciting"

So the reality is it will be months before we prove up the clinical trial and see any partner agreement - which is going to be the big driver of share price here.

I invite all to read through the announcement on Nov 24 when getting impatient, to help quell the frustration!